For the latest COVID-19 information for Massey, visit


News Center

Latest News

Center News & Funding, Community Engagement & Health Equity, Research

VCU Massey Cancer Center recognized for clinical trial enrollment efforts

Jan 23, 2023


VCU Massey Cancer Center has earned a spot as a top accruer with the Alliance for Clinical Trials in Oncology, a national clinical trials network sponsored by the National Cancer Institute (NCI). Massey’s Minority/Underserved NCI Community Oncology Research Program (MU-NCORP) ranked 30th among the Alliance main members based on its enrollment efforts toward treatment and cancer control trials between January 2020 and December 2022. 

“Increasing the enrollment of minorities and underserved patients in clinical trials is an important mission of the NCI to diversify trial participants and address disparities in cancer,” said Asit Paul, M.D., Ph.D., who was recently awarded a ‘Gold Certificate of Excellence’ by the NCI as a recognition of his contribution in patient enrollment in MU-NCORP trials. “This news is a reflection of Massey’s strong and continued commitment to this mission.” Paul is a hematologist-oncologist, chair of the Data and Safety Monitoring Committee and co-leader of the Urologic Oncology Disease Working Group at Massey, and serves as the site principal investigator for the MU-NCORP Alliance Trials.

Massey has been a top 40 accruing Alliance Main member since 2015. Its MU-NCORP allows patients, particularly minority and underserved individuals, to access prevention, early detection and treatment clinical trials as well as cancer care delivery research closer to home.

By bringing cancer clinical research studies to individuals in their own communities, the NCORP research reflects national diversity so the evidence generated contributes to improved patient outcomes and a reduction in cancer disparities for all people. As a MU-NCORP, Massey’s site reflects a patient population comprised of at least 30% racial or ethnic minorities or rural residents.

Massey partners with nine health systems and oncology medical practices statewide to facilitate the activation and enrollment of community-based oncology clinical trials. Massey is one of only 14 MU-NCORPs in the country and in 2022 earned a Gold Certificate of Excellence for accruing 174 participants on clinical trials between August 2021 and July 2022.

Community members interested in learning more about trials available to them can reach out to or explore our affiliate locations on our website.

Written by: Annie Harris

Related News

Community Engagement & Health Equity, Center News & Funding

Community seed grant in review 2022: Fifth Baptist Church

Community Engagement & Health Equity, Center News & Funding

Community seed grant in review 2022: Ebenezer Baptist Church

Get access to new, innovative care

Get access to new, innovative care

Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.

Search clinical trials
Find a provider

Find a provider

Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.

Find a provider